The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBloomsbury Share News (BMY)

Share Price Information for Bloomsbury (BMY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 530.00
Bid: 528.00
Ask: 534.00
Change: -6.00 (-1.12%)
Spread: 6.00 (1.136%)
Open: 540.00
High: 540.00
Low: 526.00
Prev. Close: 536.00
BMY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sunday share tips: Marks and Spencer, Bloomsbury

Sun, 20th Dec 2020 19:40

(Sharecast News) - The Sunday Times's Sam Chambers thinks investors should 'buy' stock in Marks&Spencer, arguing that the retailer is finally taking radical measures to turn around its fortunes.







Key among the latter was the firm's acquisition of a 50% stake in Ocado's online food unit which had seen sales surge by 35% last quarter.

Writing in his 'Inside the City' column, Chambers said: "Despite its drawbacks, the venture gives Norman a real growth story to sell for the first time in years.

"And with the shares having taken a battering, potential rewards outweigh the risks. Buy."

Chambers also cited recent backing for the firm from The Analyst, the well-regarded research shop in the City who urged clients earlier in December to buy the shares.

Then there was M&S's stated interest in acquiring Jaeger, Victoria's Secret, and parts of Arcadia Group, which Chamber said showed it was "finally accepting it cannot stop the rot without some bold action."

There was also the possibility that Marks&Spencer might sell the remainder of its international business to strengthen the balance sheet and perhaps even a chance that might revive plans to spin off its clothing business.



The Financial Mail on Sunday's Midas column recommended shares in the publisher of the Harry Potter saga, Bloomsbury, to its readers, predicting that the stock was headed higher.

Contrary to what Bloomsbury chief, Nigel Newton, had anticipated at the start of the pandemic, the company's sales did not fall off a cliff, nor did its profits.

Over the six months ending in September, the group's profits in fact leapt 60% higher to £4m.

That should have been no surprise given Britons' desire to entertain themselves through the strict lockdowns.

In parallel, over the first half of its financial year, revenues at Bloomsbury Digital Resources had jumped by 47%, stoked by demand from schools and universities around the world for online teaching.

Bloomsbury's dividend, which was reinstated in October, is expected to reach a total of 8.2p per share for the year ending in February, rising to 8.5p during the following year.

Before Covid-19, the firm had raised the dividend for 25 years straight.

"Some brokers believe profits will fall in the current year but analysts have often underestimated Bloomsbury in the past and, if current momentum continues, their predictions may prove overly pessimistic again. Either way, growth is expected to resume from 2022.

"Midas verdict: There is little to beat a good yarn and Bloomsbury seems particularly good at picking the best of them. At £2.79, the shares offer long-term potential and the dividend adds an extra kicker."
More News
26 Mar 2018 21:56

Reuters Health News Summary

Following is a summary of current health news briefs. Biohaven plunges as investors pit migraine data against Allergan's drug Biohaven Pharmaceutical Holding said its acute two a

Read more
26 Mar 2018 13:56

Reuters Health News Summary

Following is a summary of current health news briefs. Singapore pharma on recovery path after worst output in decades Singapore's among

Read more
26 Mar 2018 13:56

Reuters Health News Summary

Following is a summary of current health news briefs. Singapore pharma on recovery path after worst output in decades Singapore's among

Read more
26 Mar 2018 07:23

UPDATE 1-Roche's Tecentriq cocktail notches another lung cancer success

ZURICH, March 26 (Reuters) - Roche's immunotherapy Tecentriq combined with other drugs boosted lung cancer patients' survival versus an older cocktail, the Swiss trial

Read more
25 Mar 2018 14:15

Israel to launch Big Data health project

By Maayan Lubell JERUSALEM, March 25 (Reuters) - Israel will invest nearly 1 billion shekels ($287 million) in a to a

Read more
20 Mar 2018 07:05

UPDATE 1-Roche says Tecentriq, chemo cut risk of death in type of lung cancer

ZURICH, March 20 (Reuters) - Roche's immunotherapy Tecentriq plus chemotherapy cut the risk of disease worsening or death in advanced squamous lung cancer, but it did not

Read more
19 Mar 2018 17:59

Bloomsbury Publishing Expecting Profitability To Beat Expectations

LONDON (Alliance News) - Bloomsbury Publishing PLC said on Monday it expects its full-year profit and revenue to both be ahead of expectations.For the year ending 28 to

Read more
20 Jan 2017 09:08

Bloomsbury Publishing Says Chairman Salz To Step Down In July

Read more
27 Oct 2016 07:43

Bloomsbury Publishing Sees Stronger Second Half As Trading In Line

Read more
13 Jul 2016 12:55

Bloomsbury Publishing plots expansion into B2B market

(ShareCast News) - Harry Potter publisher Bloomsbury Publishing held a capital markets day for investors and analysts on Wednesday to present plans to enter the business-to-business market, while also confirming first-quarter trading remained in line with full year expectations. Bloomsbury unveiled

Read more
13 Jul 2016 08:20

Bloomsbury Publishing Says Full Year Trading To Meet Expectations

Read more
12 Jul 2016 15:11

UK Shareholder Meetings Calendar - Next 7 Days

Read more
8 Jul 2016 15:00

UK Shareholder Meetings Calendar - Next 7 Days

Read more
19 May 2016 12:43

Bloomsbury moves towards digital B2B after strong FY

(ShareCast News) - Bloomsbury, the publisher behind the Harry Potter phenomenon, has turned in an overall strong set of full-year results and launched a 2020 strategy to move into digital B2B publishing. It booked a full-year pretax profit of £10.36m, from a year-earlier profit of £9.60m, with reven

Read more
19 May 2016 08:18

Bloomsbury To Reoganise Divisions As Profit Lifted By Children's Books

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.